Pharmacokinetic-drug interactions. Significance for herbal medicinal products?;Arzneimittelinteraktionen: Relevanz für phytopharmaka?

Zeitschrift fur Phytotherapie

Volumn 25, Issue 6, 2004, Pages 283-288

  Schulz, Volker ^a  

^a NONE   (Germany)

Author keywords

Beverages; Drug interactions; Food; Herbal medicinal products; Lifestyle products; Secondary substances of plants; Xenobiotics biotransformation

Indexed keywords

CYCLOSPORIN A; CYTOCHROME P450; DILTIAZEM; GLYCOPROTEIN P; HERBACEOUS AGENT; ITRACONAZOLE;

ARTICLE; CARBONATED BEVERAGE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG TRANSFORMATION; HERB DRUG INTERACTION; HONEY; HUMAN; HYPERICUM; NONHUMAN; RED WINE;

EID: 11944257755     PISSN: 0722348X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Bailey DC, Spence JD, Edgar B, Bayliff CD, Arnold JM: Ethanol enhances the hemodynamic effects of felodipine. Clin Invest Med 1989; 12: 357-362.
2. Bailey DC, Spence JD, Munoz C, Arnold JM: Interaction of citrus juices with felopidine
3. Bano C, Raina RK, Zutshi U, et al.: Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers. Eur J Clin Pharmacol 1991;41:615-617.
4. BfArM - Bundesinstitut für Arzneimittel und Medizinprodukte: Bewertung möglicher pharmakokinetischer Arzneimittel-Interaktionen mit Phytopharmaka (Entwurf) 2004. www.bfarm.de/de/Arzneimittel/bes_therap/ am_pflanzl/int_20040116.pdf.
5. Butterweck V, Derendorf H, Gaus W, Nahrstedt A, Schulz V, Unger M: Pharmacokinetic herb-drug interactions: Are preventive screenings necessary and appropriate? Planta Med 2004; 70:784-791.
6. Conney AH, Pantuck EJ, Hsiao KC, et al. (1976) Enhanced phenacetin metabolism in human subjects fed charcoal-broiled beef. Clin Pharmacol Ther 1976; 20: 633-642.
7. Ernst E: Possible interactions between synthetic and herbal medicinal products. Part 1: a systematic review of the indirect evidence. Perfusion 2000; 13: 4-15.
8. Foster BC, Vandenhoek S, Hana J, et al.: In vitro inhibition of human cytochrome P450-mediated metabolism of marker substrates by natural products. Phytomedicine 2003; 10: 334-342.
9. Hall SD, Wang Z, Huang SM, Hammann MA, et al.: The interaction between St John's wort and oral contraceptive. Clin Pharmacol Ther 2003; 74: 525-535.
10. Hammerness P, Basch E, Ulbricht C, et al.: St. John's Wort: A systematic review of adverse effects and drug interactions fort he consultation psychiatrist. Psychosomatics 2003; 44: 271-282.
11. Harris RZ, Jang GR, Tsunoda S: Dietary effects on drug metabolism. Clin Pharmacokinet 2003; 42: 1071-1088.
12. Henderson L, Yue QY, Bergquist C, et al.: St. John's Wort (Hypericum perforatum): drug interactions and clinical outcomes. Br J Clin Pharmacol 2002; 54: 349-356.
13. Hohl K, Gaus W: Bibliography on Herb-Drug and Food-Drug Interactions. Universität Ulm, 2004. http://www.uni-ulm.de/uni/fak/medizin/biodok/v4/ herb_drug_interactions.html.
14. Izzo AA, Ernst E: Interactions between herbal medicines and prescribed drugs. A systematic review. Drugs 2001; 61: 2163-2175.
15. Jaruratanasirikul S, Kleepkaew A: Influence of an acidic beverage (Coca-Cola) on the absorption of itraconazole. Eur J Clin Pharmacol 1997; 52: 235-237.
16. Kall MA, Vang O, Clausen J: Effects of dietary broccoli on human in vivo drug metabolizing enzymes: evaluation of caffeine, oestrone and chlorzoxazone metabolism. Carcinogenesis 1996; 17: 793-799.
17. Koumaravelou K, Adithan C, Shashindran CH, et al.: Influence of honey on orally and intravenously administered diltiazem kinetics in rabbits. Indian J Exp Biol 2002; 40: 1164-1168.
18. Lampe JW, King IB, Li S, et al.: Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 activity in humans: changes in caffeine metabolite ratios in response to controlled vegetable diets. Carcinogenesis 2000; 21: 1157-1162.
19. Lazarus SA: Tomato juice and platelet aggregation in type 2 diabetics. JAMA 2004; 292: 805-806.
20. Leclercq I, Desager JP, Horsmann Y: Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestion of watercress. Clin Pharmacol Ther 1998; 64: 144-149.
21. Malhotra S, Bailey DC, Paine MF, et al.: Seville orange juice felopidine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins. Clin Pharmacol Ther 2001; 69: 14-23.
22. Monks TJ, Caldwell J, Smith RL: Influence of methylxanthine-containing foods on the theophyllin metabolism and kinetics. Clin Pharmacol Ther 1979; 26: 513-524.
23. Paine MF, Khalighi M, Fisher JM, et al.: Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. J Pharmacol Exp Ther 1997; 283: 1552-1562.
24. Pantuck EJ, Pantuck CB, Anderson KE, et al.: Effects of Brussels sprouts and cabbage on drug conjugations in humans. Clin Pharmacol Ther 1984; 35: 161-169.
25. Pantuck EJ, Pantuck CB, Garland WA, et al.: Stimulatory effect of Brussels sprouts and cabbage on human drug metabolism. Clin Pharmacol Ther 1979; 25: 88-95.
26. Pfrunder A, Schiesser M, Gerber S, et al.: Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial. Br J Cin Pharmacol 2003; 56: 683-690.
27. Piscitelli SC, Burstein AH, Welden N, Gallicano KD, Falloon J: The effect of garlic supplements on the pharmacokinetics of saquinavir. CID 2002; 34: 234-238.
28. Schulz V: Incidence and clinical relevance of the interactions and side effects of Hypericum preparations. Phytomedicine 2001; 8: 152-160.
29. Schulz V, Johne A: Side effects and drug interactions. In: Müller WE (ed.) St. John's Wort and its Active Principles in Depression and Anxiety. Milestones in Drug Therapy. Basel, Boston: Birkhäuser, 2004.
30. Strandell J, Neil A, Carlin C: An approach to the in vitro evaluation of potential for cytochrome P450 enzyme inhibition from herbals and other natural remedies. Phytomedicine 2004; 11: 98-104.
31. Tsunoda SM, Harris RZ, Christians U, et al.: Red wine decreases cyclosporine bioavailability. Clin Pharmacol Ther 2001; 70: 462-467.
32. Unger M: Wie Naturstoffe die Bioverfügbarkeit von Arzneistoffen beeinflussen. Pharm Ztg 2004; 149: 979-986.
33. Unger M: Arzneimittelneben- und Wechselwirkungen durch Phytopharmaka. Z Phytotherapie 2004; 25: 171-178.
34. Vistisen K, Loft S, Poulson HE: Cytochrome P450 2A2 activity in man measured by caffeine metabolism: Effect of smoking, broccoli and exercise. Adv Exp Med Biol 1991; 283: 407-411.